Table 3 Basic characteristics, blinding efficacy, and self-reported side effects of participants in experiment 2.
From: Enhancing response inhibition through a novel tES-fNIRS framework
tACS (n = 42) | tDCS (n = 42) | sham (n = 40) | P | |
|---|---|---|---|---|
Mean ± SD | Mean ± SD | Mean ± SD | ||
Age(years) | 22.71 ± 3.10 | 21.69 ± 2.28 | 21.78 ± 2.47 | 0.149 |
Education(years) | 16.86 ± 2.16 | 15.98 ± 2.16 | 16.25 ± 1.98 | 0.150 |
Number of correct guesses(active) | 40 (95.24%) | 41 (97.62%) | 36 (90.00%) | |
Confidence in correct guesses(active) | 2.85 ± 0.36 | 2.76 ± 0.54 | 2.86 ± 0.42 | |
Number of correct guesses(sham) | 1 (2.86%) | 1 (2.86%) | 1 (2.86%) | |
Confidence in correct guesses(sham) | 3 | 2 | 2 | |
Number of correct guesses(uncertain) | 1 (2.38%) | 0 (0.00%) | 3 (7.50%) | |
Confidence in correct guesses(uncertain) | 2 | 0 | 2 | |
Itching | 8 (19.05%) | 6 (14.29%) | 6 (15.00%) | |
Skin redness | 0 | 0 | 0 | |
Headache | 1 (2.38%) | 1 (2.38%) | 1 (2.50%) | |
Cervical pain | 0 | 0 | 1 (2.50%) | |
Distraction | 1 (2.38%) | 1 (2.38%) | 1 (2.50%) | |
Acute mood variation | 0 | 0 | 0 | |
Sleepiness | 2 (4.76%) | 3 (7.14%) | 3 (7.50%) |